These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26584013)

  • 21. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?
    Croome KP; Lee DD; Pungpapong S; Keaveny AP; Taner CB
    Liver Transpl; 2018 Apr; 24(4):497-504. PubMed ID: 29341398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The true merits of liver allocation according to MELD scores: survival after transplantation tells only one side of the story.
    Metselaar HJ; Lerut J; Kazemier G
    Transpl Int; 2011 Feb; 24(2):132-3. PubMed ID: 21208292
    [No Abstract]   [Full Text] [Related]  

  • 24. Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients.
    Aranzana EM; Coppini AZ; Ribeiro MA; Massarollo PC; Szutan LA; Ferreira FG
    Clinics (Sao Paulo); 2015 Jun; 70(6):413-8. PubMed ID: 26106959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Living donor liver transplantation in high Model for End-Stage Liver Disease score patients.
    Feng S
    Liver Transpl; 2017 Oct; 23(S1):S9-S21. PubMed ID: 28719072
    [No Abstract]   [Full Text] [Related]  

  • 26. Model for end-stage liver disease: end of the first decade.
    Asrani SK; Kim WR
    Clin Liver Dis; 2011 Nov; 15(4):685-98. PubMed ID: 22032523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living donor liver transplantation with body-weight more or less than 10 kilograms.
    Yang SC; Huang CJ; Chen CL; Wang CH; Wu SC; Shih TH; Juang SE; Lee YE; Jawan B; Cheng YF; Cheng KW
    World J Gastroenterol; 2015 Jun; 21(23):7248-53. PubMed ID: 26109812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined heart-liver transplantation; implications for liver-alone wait list mortality.
    Sulewski ME; Wolf JH; Hasz R; West S; Goldberg D; Krok KL; Olthoff KM; Shaked A; Levine MH; Abt PL
    Transplantation; 2014 Sep; 98(5):e45-7. PubMed ID: 25171534
    [No Abstract]   [Full Text] [Related]  

  • 29. Survival tree and MELD to predict long term survival in liver transplantation waiting list.
    do Nascimento EM; Pereira Bde B; Basto ST; Ribeiro Filho J
    J Med Syst; 2012 Feb; 36(1):73-8. PubMed ID: 20703747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Waiting for a liver transplant..
    Chapman J
    Intern Med J; 2010 Sep; 40(9):609-10. PubMed ID: 20840211
    [No Abstract]   [Full Text] [Related]  

  • 31. Current Status of Simultaneous Liver-Kidney Transplantation in the United States.
    Lum EL; Cárdenas A; Martin P; Bunnapradist S
    Liver Transpl; 2019 May; 25(5):797-806. PubMed ID: 30861294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the threshold for too sick for transplant.
    Lai JC
    Curr Opin Organ Transplant; 2016 Apr; 21(2):127-32. PubMed ID: 26825359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Managing a vital resource: liver graft allocation].
    Duvoux C
    Bull Acad Natl Med; 2013 Mar; 197(3):589-98. PubMed ID: 25163342
    [No Abstract]   [Full Text] [Related]  

  • 34. Model for End-Stage Liver Disease and Seven Derivations to Prioritize Liver Transplant Candidates: Which Is the Winner?
    Tohidinezhad F; Eslami S; Abu-Hanna A; Aliakbarian M
    Exp Clin Transplant; 2018 Dec; 16(6):721-729. PubMed ID: 29457445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celiac Axis Extension Grafts in Orthotopic Liver Transplantation.
    Geha JA; Thao Galvan N; Kueht M; Yoeli D; Geha JD; Rana A; Cotton RT; O'Mahony CA; Goss JA
    Liver Transpl; 2018 Aug; 24(8):1138-1141. PubMed ID: 29684248
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions.
    Fleming JN; Taber DJ; Pilch NA; Mardis CR; Gilbert RE; Wilson LZ; Patel N; Ball S; Mauldin P; Baliga PK
    J Am Coll Surg; 2018 Apr; 226(4):651-659. PubMed ID: 29309943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results after spouse donations in living-donor liver transplantation: Does HLA matching impact long-term survival?
    Jeng LB; Thorat A; Yang HR; Yeh CC; Chen TH; Hsu SC
    Surgery; 2016 Jul; 160(1):251-252. PubMed ID: 27038762
    [No Abstract]   [Full Text] [Related]  

  • 38. A bridge too far: We have not overstepped the line for extended deceased donors.
    Fondevila C
    Liver Transpl; 2014 Nov; 20 Suppl 2():S9-13. PubMed ID: 25220866
    [No Abstract]   [Full Text] [Related]  

  • 39. A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era.
    Parikh A; Washburn KW; Matsuoka L; Pandit U; Kim JE; Almeda J; Mora-Esteves C; Halff G; Genyk Y; Holland B; Wilson DJ; Sher L; Koneru B
    Liver Transpl; 2015 Sep; 21(9):1160-8. PubMed ID: 25991395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Transplantation in Patients with Sickle Cell Disease in the United States.
    Hogen R; Kim M; Lee Y; Lo M; Kaur N; Kahn J; Chopra S; Qazi Y; Sedra A; Kim J; O'Brien L; Genyk Y; Sher L; Emamaullee J
    J Surg Res; 2020 Nov; 255():23-32. PubMed ID: 32540577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.